196 related articles for article (PubMed ID: 22881141)
1. A botulinum neurotoxin-like function of Potentilla chinensis extract that inhibits neuronal SNARE complex formation, membrane fusion, neuroexocytosis, and muscle contraction.
Jung CH; Choi JK; Yang Y; Koh HJ; Heo P; Yoon KJ; Kim S; Park WS; Shing HJ; Kweon DH
Pharm Biol; 2012 Sep; 50(9):1157-67. PubMed ID: 22881141
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of SNARE-driven neuroexocytosis by plant extracts.
Jung CH; Yang YS; Kim JS; Shin YK; Hwang JS; Son ED; Lee HH; Chung KM; Oh JM; Lee JH; Kweon DH
Biotechnol Lett; 2009 Mar; 31(3):361-9. PubMed ID: 19023663
[TBL] [Abstract][Full Text] [Related]
3. A search for synthetic peptides that inhibit soluble N-ethylmaleimide sensitive-factor attachment receptor-mediated membrane fusion.
Jung CH; Yang YS; Kim JS; Shin JI; Jin YS; Shin JY; Lee JH; Chung KM; Hwang JS; Oh JM; Shin YK; Kweon DH
FEBS J; 2008 Jun; 275(12):3051-63. PubMed ID: 18459979
[TBL] [Abstract][Full Text] [Related]
4. SNARE-wedging polyphenols as small molecular botox.
Yang Y; Choi JK; Jung CH; Koh HJ; Heo P; Shin JY; Kim S; Park WS; Shin HJ; Kweon DH
Planta Med; 2012 Feb; 78(3):233-6. PubMed ID: 22109835
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of synaptic neurotransmitter release mechanisms using bacterial toxins].
Doussau F; Humeau Y; Vitiello F; Popoff MR; Poulain B
J Soc Biol; 1999; 193(6):457-67. PubMed ID: 10783704
[TBL] [Abstract][Full Text] [Related]
6. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.
Patel KB; Cai S; Adler M; Singh BK; Parmar VS; Singh BR
Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30389764
[TBL] [Abstract][Full Text] [Related]
7. Engineered botulinum neurotoxins as new therapeutics.
Masuyer G; Chaddock JA; Foster KA; Acharya KR
Annu Rev Pharmacol Toxicol; 2014; 54():27-51. PubMed ID: 24016211
[TBL] [Abstract][Full Text] [Related]
8. [Mechanisms of action of botulinum toxins and neurotoxins].
Poulain B; Lonchamp E; Jover E; Popoff MR; Molgó J
Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S73-6. PubMed ID: 19576489
[TBL] [Abstract][Full Text] [Related]
9. Longer-acting and highly potent chimaeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and B.
Wang J; Zurawski TH; Bodeker MO; Meng J; Boddul S; Aoki KR; Dolly JO
Biochem J; 2012 May; 444(1):59-67. PubMed ID: 22360156
[TBL] [Abstract][Full Text] [Related]
10. Gbetagamma acts at the C terminus of SNAP-25 to mediate presynaptic inhibition.
Gerachshenko T; Blackmer T; Yoon EJ; Bartleson C; Hamm HE; Alford S
Nat Neurosci; 2005 May; 8(5):597-605. PubMed ID: 15834421
[TBL] [Abstract][Full Text] [Related]
11. Is the light chain subcellular localization an important factor in botulinum toxin duration of action?
Fernández-Salas E; Ho H; Garay P; Steward LE; Aoki KR
Mov Disord; 2004 Mar; 19 Suppl 8():S23-34. PubMed ID: 15027051
[TBL] [Abstract][Full Text] [Related]
12. Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators.
Dolly JO; Wang J; Zurawski TH; Meng J
FEBS J; 2011 Dec; 278(23):4454-66. PubMed ID: 21645262
[TBL] [Abstract][Full Text] [Related]
13. Buforin-1 blocks neuronal SNARE-mediated membrane fusion by inhibiting SNARE complex assembly.
Lee JG; Ko YJ; Choi JH; Jo MJ; Jun Y; Kim JI
Biochem Biophys Res Commun; 2019 Jun; 514(1):105-111. PubMed ID: 31027731
[TBL] [Abstract][Full Text] [Related]
14. SNARE zippering is hindered by polyphenols in the neuron.
Yang Y; Kim SH; Heo P; Kong B; Shin J; Jung YH; Yoon K; Chung WJ; Shin YK; Kweon DH
Biochem Biophys Res Commun; 2014 Jul; 450(1):831-6. PubMed ID: 24960195
[TBL] [Abstract][Full Text] [Related]
15. Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential.
Meng J; Wang J; Lawrence G; Dolly JO
J Cell Sci; 2007 Aug; 120(Pt 16):2864-74. PubMed ID: 17666428
[TBL] [Abstract][Full Text] [Related]
16. New and emerging indications of botulinum toxin therapy.
Kaji R
Parkinsonism Relat Disord; 2011 Nov; 17 Suppl 1():S25-7. PubMed ID: 21999892
[TBL] [Abstract][Full Text] [Related]
17. Investigating novel therapeutic targets and molecular mechanisms to treat botulinum neurotoxin A intoxication.
Eubanks LM; Dickerson TJ
Future Microbiol; 2007 Dec; 2(6):677-87. PubMed ID: 18041908
[TBL] [Abstract][Full Text] [Related]
18. Dual inhibition of SNARE complex formation by tomosyn ensures controlled neurotransmitter release.
Sakisaka T; Yamamoto Y; Mochida S; Nakamura M; Nishikawa K; Ishizaki H; Okamoto-Tanaka M; Miyoshi J; Fujiyoshi Y; Manabe T; Takai Y
J Cell Biol; 2008 Oct; 183(2):323-37. PubMed ID: 18936251
[TBL] [Abstract][Full Text] [Related]
19. Targeted delivery into motor nerve terminals of inhibitors for SNARE-cleaving proteases via liposomes coupled to an atoxic botulinum neurotoxin.
Edupuganti OP; Ovsepian SV; Wang J; Zurawski TH; Schmidt JJ; Smith L; Lawrence GW; Dolly JO
FEBS J; 2012 Jul; 279(14):2555-67. PubMed ID: 22607388
[TBL] [Abstract][Full Text] [Related]
20. Poisoning by botulinum neurotoxin A does not inhibit formation or disassembly of the synaptosomal fusion complex.
Otto H; Hanson PI; Chapman ER; Blasi J; Jahn R
Biochem Biophys Res Commun; 1995 Jul; 212(3):945-52. PubMed ID: 7626135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
